GHP Funds


SVP I, the debut fund for the firm, closed in December 2002 and invested with four highly successful leveraged buyout funds. SVP I is diversified by sector and geography.

Learn More

SVP II is a leveraged buyout fund of funds which closed in December 2006. SVP II represents a continuation of the successful strategy utilized by the predecessor fund, primarily investing with large, top tier LBO and growth equity firms. SVP II is diversified by sector and geography.

Learn More

SVP Real Estate I, LP ("SVP RE I"), closed in February 2008, is a private real estate fund of funds. As with SVP I & II, SVP RE I received allocations with historically successful, highly sought after underlying fund managers who pursue compelling investment strategies. The fund is diversified by sector (Office, Hotel, Industrial/Warehouse, Retail and Residential) and geography (U.S., Europe, and Asia/Pacific).

Learn More

The GHP Credit Opportunity Fund (“GHP COF”) is a fund of alternative credit and distressed debt funds that is being raised and invested to pursue two specific investment themes: (1) the de-leveraging of European Banks, and (2) the potential for a distressed cycle in U.S. High Yield Credit. GHP COF will pursue complex liquid and illiquid credit opportunities in the U.S. and Europe.

Learn More

GHP Library

Ohio awards medical marijuana grow license after resolving error in process

Trying to rectify an application scoring error, Ohio regulators issued a medical marijuana cultivation license to Illinois-based PharmaCann Ohio, which had been rejected in the original round of license review.

According to the Cleveland Plain-Dealer, the company will receive a provisional permit for a 25,000 square-foot operation in Buckeye Lake, roughly 30 miles outside the state capital, Columbus.

The permit is the 25th license for a program that initially planned to issue only 24 cultivation licenses. It’s unclear how the Department of Commerce was able to issue the additional license.

Ohio regulators have been under attack for errors made in the licensing process.

Here’s what you need to know:

  • In February, regulators discovered an employee had botched the scores for 10 companies, and PharmaCann was the only company in the group not awarded a license after the mistake.
  • PharmaCann initially scored 12th for a large-scale cultivation license but didn’t receive a permit because regulators gave licenses to two lower-scoring companies under a provision in the law that gave preference to minority-owned businesses.
  • PharmaCann filed suit, saying the state’s “racial quota” was unconstitutional.
  • Under state law, Ohio’s MMJ program must be up and running by Sept. 8. The Plain Dealer reported that some growers expect to get the green light to begin growing this month.
  • Processor and dispensary licenses are expected to be awarded in the coming weeks.

Leave a Comment